News: API Australian Pharmaceutical Industries Entered Scheme Implementation Deed With Wesfarmers

Nov 8 (Reuters) - Australian Pharmaceutical Industries Ltd (API) :

• ENTERED INTO A SCHEME IMPLEMENTATION DEED WITH WESFARMERS
• AUSTRALIAN PHARMACEUTICAL INDUSTRIES LTD- API BOARD UNANIMOUSLY RECOMMENDS THAT API SHAREHOLDERS VOTE IN FAVOUR OF SCHEME
• IT IS ANTICIPATED SCHEME TRANSACTION WILL COMPLETE IN Q1 OF CALENDAR YEAR 2022
• INTENDS TO PAY A FULLY FRANKED SPECIAL DIVIDEND OF UP TO 3 AU CENTS PER SHARE AS PART OF SCHEME IMPLEMENTATION
• WESFARMERS HAS COMPLETED ITS DUE DILIGENCE AND RECONFIRMED ITS PROPOSAL TO ACQUIRE 100% OF SHARES IN API
• ANTICIPATED SCHEME TRANSACTION WILL COMPLETE IN Q1 OF CALENDAR YEAR 2022